Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 245-022-3
CAS number: 22473-78-5
There are no repeated dose studies with tetraammonium EDTA available. However, under physiological conditions (pH 7-9) any EDTA salt as well as edetic acid will dissociate into the cations and the respective anionic species of edetic acid depending on the dissociation equilibria of edetic acid. Under the assumption of this equivalence it is likely that all EDTA salt chelate ions in vivo. Therefore repeated dose studies with other EDTA-salts, such as Na2EDTA and Na3EDTA, have been used as read across. (For read-across justification refer to section 13).A 90 day (Na2EDTA) as well as a 2 years (Na3EDTA) feeding study on rats provide reliable toxicological information for an overall NOAEL of about 500 mg/kg bw.A NOAEC value of 3 mg/m³ air was established in a subchronic toxicity study with Na2H2EDTA.It can also be ruled out that at this concentrations ammonium ions may cause any toxic effect, as ammonium ions are converted to urea in the liver or are utilized to form in amino acids and proteins. There is only a limited number on repeated dose studies with other ammonium salts available, however oral studies on rats with NH4Cl or ammonium sulfate report even higher NOAELs.
A 90 days
feeding study of Na2EDTA in rats revealed a NOAEL of 500 mg/kg bw (Wynn,
1970). Groups of 10 male Holzman rats received 1, 5 and 10%
(respectively 500 mg/kg bw; 2,500 mg/kg bw and 5,000 mg/kg bw) Na2EDTA
in the diet for 90 days. The mid and high dose animals expressed a
significant decrease of body weights and food consumption. Dose
dependent mortality was evident by 20% in the 5% and 60% in the 10%
group. In these groups animals exhibited diarrhea and were emaciated.
Water consumption was increased. In the upper dose there was an
intermittent decrease of hematocrite and hemoglobin levels, livers
appeared to be pale. Histological investigation failed to reveal any
pathological alteration. From this investigation, a NOAEL of 500
mg/kg/day equivalent to 1% in diet can be deduced for male rats. It
should be noted that in this study no complete clinical biochemistry has
been performed as required by OECD 408 guideline.
A two year
feeding study with (Na3EDTA x 3H2O) to rats revealed a NOAEL of 500
mg/kg/day (corresponding to 7,500 ppm in the diet) (NTIS, 1977). In this
feeding study with two dose levels 3,750 ppm and 7,500 ppm
(corresponding to approximately 250 and 500 mg/kg/day) no substance
related toxic effects could be observed.
study at the same dose levels (3,750 ppm and 7,500 ppm; corresponding to
approximately 469 and 938 mg/kg/day) conducted with mice showed a NOAEL
of 938 mg/kg bw/day. There were also no treatment related changes.
A one month
feeding study of Na2EDTA in rats revealed a NOAEL of 1,125 mg/kg bw
(this corresponds to 2.25% in the diet) (Kawamata, 1980). In this study
test substance was incorporated at levels of 1, 2.25 and 5% in the diet
(this corresponds to 500, 1125 and 2500 mg/kg bw). 15 rats per sex and
dose level were exposed over a period of one month. At the upper dose
level body weight decrease, some mortalities and a reduction of total
leucocytes and lymphocytes as well as an increase of bound urine
nitrogen (BUN) and a decrease Ca serum levels were found. Pathological
investigation at this dose level revealed a decrease of liver, spleen
and thymus weight. Some parakeratosis was detected in the oesophagus and
forestomach by histopathology.
subacute repeated dose toxicity study (BASF, 2009) 10 male Wistar rats
per concentration were exposed to a respirable dust aerosol of Na2H2EDTA
for 6 hours per day for 5 consecutive days at concentrations of 0, 30,
300, 1000 mg/m³ air.
the high dose group (1000 mg/m3) was for one day only due to mortality
observed. Inhalation exposure to 1000 mg/m³ disodium EDTA for 6 hours
caused lethality in 6 out of 20 male rats. Histological examination of
the lung of the dead rats revealed congestion, edema, multifocal
hemorrhages and inflammatory cell infiltrates.
exposure of rats to Na2H2EDTA for 6 hours per day, 5 consecutive days
caused concentration-dependent lesions in the larynx and lungs that were
fully reversible within 14 days. Due to histopathological changes in the
low dose group a No-Observed-Adverse-Effect-Concentration could not be
determined. The LOAEC was considered to be 30 mg/m³ air.
was planned as range finder study and conducted according to OECD
subchronic repeated dose toxicity study (BASF, 2014) according to to
OECD guideline No. 413 Wistar rats were exposed to a respirable dust
aerosol of Na2H2EDTA for 6h/d on 5 consecutive d/w for 13 weeks (65
exposures in total) at concentrations of 0, 0.5, 3, 15 mg/m3 air.
exposure of rats to Na2H2EDTA did not lead to any substance-related
clinical signs of toxicity. Nor were there any effect in clinical
chemistry, hematology. Histological examination revealed some effects in
larynx at the highest tested concentration of 15 mg/m³. No signs of
systemic toxicity were observed up to a concentration of 15 mg/m³.
local toxicity were observed only at the high concentration of 15 mg/m³.
Under the current test conditions, the No Observed Adverse Effect
Concentration (NOAEC) for local effect in larynx was 3 mg/m3, the NOEC
for systemic effect is 15 mg/m³.
key effect of respirable Na2H2EDTA in the respiratory tract (larynx) is
assumed to be mainly concentration-related, hence the impact of exposure
time should be low at subcritical concentrations, which was confirmed by
the 90d study: although the number of exposures was factor 13 higher
than in the 5d dose-range-finder study, the local effects at 15 mg/m3in
the subchronic inhalation study were comparably mild compared to the 5d
dose-range-finder study that showed a more severe effect at 30 mg/m3.
the results obtained in the toxicity studies and taking into account the
provisions laid down in Council Directive 67/548/EEC and CLP, a
classification as Xn (R48/20) and STOT RE Cat 2 (H373) is justified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again